53BP1 ablation rescues genomic instability in mice expressing ‘RING‐less’ BRCA1
- 26 September 2016
- journal article
- research article
- Published by Springer Nature in EMBO Reports
- Vol. 17 (11) , 1532-1541
Abstract
BRCA1 mutations strongly predispose affected individuals to breast and ovarian cancer, but the mechanism by which BRCA1 acts as a tumor suppressor is not fully understood. Homozygous deletion of exon 2 of the mouse Brca1 gene normally causes embryonic lethality, but we show that exon 2‐deleted alleles of Brca1 are expressed as a mutant isoform that lacks the N‐terminal RING domain. This “RING‐less” BRCA1 protein is stable and efficiently recruited to the sites of DNA damage. Surprisingly, robust RAD51 foci form in cells expressing RING‐less BRCA1 in response to DNA damage, but the cells nonetheless display the substantial genomic instability. Genomic instability can be rescued by the deletion of Trp53bp1 , which encodes the DNA damage response factor 53BP1, and mice expressing RING‐less BRCA1 do not show an increased susceptibility to tumors in the absence of 53BP1. Genomic instability in cells expressing RING‐less BRCA1 correlates with the loss of BARD1 and a defect in restart of replication forks after hydroxyurea treatment, suggesting a role of BRCA1–BARD1 in genomic integrity that is independent of RAD51 loading. ![][1] BRCA1 protein lacking the N‐terminal RING domain is stable and supports RAD51 focus formation at DSBs. Cells with “RING‐less” BRCA1 nonetheless show genomic instability, likely because of BARD1 loss and impaired stalled replication fork restart. EMBO Reports (2016) 17: 1532–1541 [1]: /embed/graphic-1.gifKeywords
Funding Information
- National Cancer Institute (R00CA160574)
- Rutgers Biotech Training Program (T32 GM008339)
- National Institute of General Medical Sciences (S10OD016400)
- National Institutes of Health (DP2HD087943)
This publication has 41 references indexed in Scilit:
- 53BP1 ablation rescues genomic instability in mice expressing ‘RING‐less’ BRCA1EMBO Reports, 2016
- BRCA1 Is a Histone-H2A-Specific Ubiquitin LigaseCell Reports, 2014
- BRCA1 and BRCA2: different roles in a common pathway of genome protectionNature Reviews Cancer, 2011
- BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase ActivityScience, 2011
- BRCA1 tumour suppression occurs via heterochromatin-mediated silencingNature, 2011
- E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaksProceedings of the National Academy of Sciences, 2008
- BRCA1-associated tumorigenesis: what have we learned from knockout mice?Trends in Genetics, 2001
- The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived MutationJournal of Biological Chemistry, 2001
- Brca1 Controls Homology-Directed DNA RepairMolecular Cell, 1999
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996